S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
A man fatally stabbed 4 family members before police shot and killed him; 2 officers injured
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
All the trading advice you’ve ever received boils down to this (Ad)
Lacking counselors, US schools turn to the booming business of online therapy
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
A man fatally stabbed 4 family members before police shot and killed him; 2 officers injured
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
All the trading advice you’ve ever received boils down to this (Ad)
Lacking counselors, US schools turn to the booming business of online therapy
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
A man fatally stabbed 4 family members before police shot and killed him; 2 officers injured
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
All the trading advice you’ve ever received boils down to this (Ad)
Lacking counselors, US schools turn to the booming business of online therapy
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
A man fatally stabbed 4 family members before police shot and killed him; 2 officers injured
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
All the trading advice you’ve ever received boils down to this (Ad)
Lacking counselors, US schools turn to the booming business of online therapy

Ekso Bionics (EKSO) Earnings Date, Estimates & Call Transcripts

$1.75
0.00 (0.00%)
(As of 12/1/2023 ET)
Compare
Today's Range
$1.72
▼
$1.78
50-Day Range
$0.67
▼
$1.75
52-Week Range
$0.62
▼
$1.88
Volume
31,028 shs
Average Volume
109,336 shs
Market Capitalization
$24.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Mar. 26Estimated
Actual EPS
(Oct. 26)
-$0.24 Beat By $0.07
Consensus EPS
(Oct. 26)
-$0.31
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

EKSO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EKSO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ekso Bionics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231($0.31)($0.31)($0.31) 
Q2 20231($0.23)($0.23)($0.23) 
Q3 20231($0.23)($0.23)($0.23) 
Q4 20231($0.16)($0.16)($0.16) 
FY 20234($0.93)($0.93)($0.93) 
Q1 20241($0.24)($0.24)($0.24) 
Q2 20241($0.17)($0.17)($0.17) 
Q3 20241($0.18)($0.18)($0.18) 
Q4 20241($0.16)($0.16)($0.16) 
FY 20244($0.75)($0.75) ($0.75)

EKSO Earnings Date and Information

Ekso Bionics last issued its earnings results on October 26th, 2023. The reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.31) by $0.07. The business had revenue of $4.61 million for the quarter, compared to the consensus estimate of $4.53 million. Ekso Bionics has generated ($1.12) earnings per share over the last year (($1.12) diluted earnings per share). Earnings for Ekso Bionics are expected to grow in the coming year, from ($1.29) to ($0.87) per share. Ekso Bionics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates.

Ekso Bionics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/26/2024
Estimated)		------- 
10/26/2023Q3 2023($0.31)($0.24)+$0.07($0.24)$4.53 million$4.61 million
7/27/2023Q2 2023($0.28)($0.31)($0.03)($0.31)$4.35 million$4.70 million
4/27/2023Q1 2023($0.31)($0.33)($0.02)($0.33)$2.80 million$4.12 million
3/28/2023Q4 2022-($0.24)($0.24)($0.24)-$3.55 million
11/3/2022Q3 2022($0.24)($0.33)($0.09)($0.33)$3.58 million$3.33 million
7/28/2022Q2 2022($0.24)($0.23)+$0.01($0.23)$3.49 million$3.47 million      
4/28/2022Q1 2022($0.41)($0.36)+$0.05($0.36)$3.20 million$2.57 million      
2/24/2022Q4 2021($0.25)($0.23)+$0.02($0.23)$4.00 million$4.08 million    
11/1/2021Q3 2021($0.25)($0.15)+$0.10($0.17)$2.58 million$3.05 million    
7/28/2021Q2 2021($0.25)($0.19)+$0.06($0.41)$2.14 million$2.21 million    
4/28/2021Q1 2021($0.24)($0.34)($0.10)($0.34)$3.00 million$1.91 million  
2/25/2021Q4 2020($0.30)($0.48)($0.18)($0.48)$2.30 million$2.25 million  












Ekso Bionics Earnings - Frequently Asked Questions

When is Ekso Bionics's earnings date?

Ekso Bionics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off last year's report dates. Learn more on EKSO's earnings history.

Did Ekso Bionics beat their earnings estimates last quarter?

In the previous quarter, Ekso Bionics (NASDAQ:EKSO) reported ($0.24) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.07. Learn more on analysts' earnings estimate vs. EKSO's actual earnings.

How much revenue does Ekso Bionics generate each year?

Ekso Bionics (NASDAQ:EKSO) has a recorded annual revenue of $12.91 million.

How much profit does Ekso Bionics generate each year?

Ekso Bionics (NASDAQ:EKSO) has a recorded net income of -$15.08 million. EKSO has generated -$1.12 earnings per share over the last four quarters.

What is Ekso Bionics's EPS forecast for next year?

Ekso Bionics's earnings are expected to grow from ($1.29) per share to ($0.87) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:EKSO) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -